Volume 30, Issue 4 (7-2022)                   JSSU 2022, 30(4): 4702-4705 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nabizadeh S F, Dehqan F, Khashei Varnamkhasti K. Recombinant probiotic-Based Vaccines; Attractive vehicles for immunization via mucosal routes. JSSU. 2022; 30 (4) :4702-4705
URL: http://jssu.ssu.ac.ir/article-1-5730-en.html
Abstract:   (192 Views)
Introduction: The importance of genetically modified microorganisms, including probiotics, now widely have considered as attractive vehicles for mucosal delivery of therapeutic molecules. Previous studies have indicated that mucosal administration of these molecules can effectively trigger humoral along with cellular immune responses. Therefore, development of induction of mucosal immune responses, utilizing of recombinant probiotics-based vaccines, as live delivery vectors with no side effects in humans, may contribute to effectiveness of control strategies against infection agents.

Full-Text [PDF 367 kb]   (140 Downloads)    
Type of Study: Letter to editor | Subject: Immunology
Received: 2022/05/1 | Accepted: 2022/06/8 | Published: 2022/07/6

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | SSU_Journals

Designed & Developed by : Yektaweb